275 related articles for article (PubMed ID: 17576842)
1. Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.
Kroeger LA; Hovde LB; Mitropoulos IF; Schafer J; Rotschafer JC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3431-3. PubMed ID: 17576842
[TBL] [Abstract][Full Text] [Related]
2. In vitro postantibiotic effect of colistin on multidrug-resistant Acinetobacter baumannii.
Plachouras D; Giamarellos-Bourboulis EJ; Kentepozidis N; Baziaka F; Karagianni V; Giamarellou H
Diagn Microbiol Infect Dis; 2007 Apr; 57(4):419-22. PubMed ID: 17188449
[TBL] [Abstract][Full Text] [Related]
3. Antibiograms of multidrug-resistant clinical Acinetobacter baumannii: promising therapeutic options for treatment of infection with colistin-resistant strains.
Li J; Nation RL; Owen RJ; Wong S; Spelman D; Franklin C
Clin Infect Dis; 2007 Sep; 45(5):594-8. PubMed ID: 17682994
[TBL] [Abstract][Full Text] [Related]
4. Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.
Tan CH; Li J; Nation RL
Antimicrob Agents Chemother; 2007 Sep; 51(9):3413-5. PubMed ID: 17620384
[TBL] [Abstract][Full Text] [Related]
5. In vitro effect of minocycline and colistin combinations on imipenem-resistant Acinetobacter baumannii clinical isolates.
Tan TY; Ng LS; Tan E; Huang G
J Antimicrob Chemother; 2007 Aug; 60(2):421-3. PubMed ID: 17540671
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Song JY; Kee SY; Hwang IS; Seo YB; Jeong HW; Kim WJ; Cheong HJ
J Antimicrob Chemother; 2007 Aug; 60(2):317-22. PubMed ID: 17540672
[TBL] [Abstract][Full Text] [Related]
7. Postantibiotic effects of tigecycline, colistin sulfate, and levofloxacin alone or tigecycline-colistin sulfate and tigecycline-levofloxacin combinations against Acinetobacter baumannii.
Ozbek B; Sentürk A
Chemotherapy; 2010; 56(6):466-71. PubMed ID: 21088399
[TBL] [Abstract][Full Text] [Related]
8. In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates.
Owen RJ; Li J; Nation RL; Spelman D
J Antimicrob Chemother; 2007 Mar; 59(3):473-7. PubMed ID: 17289768
[TBL] [Abstract][Full Text] [Related]
9. Colistin hetero-resistance in multidrug-resistant Acinetobacter baumannii clinical isolates from the Western Pacific region in the SENTRY antimicrobial surveillance programme.
Yau W; Owen RJ; Poudyal A; Bell JM; Turnidge JD; Yu HH; Nation RL; Li J
J Infect; 2009 Feb; 58(2):138-44. PubMed ID: 19058855
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Montero A; Ariza J; Corbella X; Doménech A; Cabellos C; Ayats J; Tubau F; Borraz C; Gudiol F
J Antimicrob Chemother; 2004 Dec; 54(6):1085-91. PubMed ID: 15546972
[TBL] [Abstract][Full Text] [Related]
11. In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii.
Dizbay M; Tozlu DK; Cirak MY; Isik Y; Ozdemir K; Arman D
J Antibiot (Tokyo); 2010 Feb; 63(2):51-3. PubMed ID: 19942947
[TBL] [Abstract][Full Text] [Related]
12. Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Tripodi MF; Durante-Mangoni E; Fortunato R; Utili R; Zarrilli R
Int J Antimicrob Agents; 2007 Dec; 30(6):537-40. PubMed ID: 17851050
[TBL] [Abstract][Full Text] [Related]
13. Colistin and tigecycline susceptibility among multidrug-resistant Acinetobacter baumannii isolated from ventilator-associated pneumonia.
Dizbay M; Altuncekic A; Sezer BE; Ozdemir K; Arman D
Int J Antimicrob Agents; 2008 Jul; 32(1):29-32. PubMed ID: 18539006
[TBL] [Abstract][Full Text] [Related]
14. Synergy of imipenem/colistin methanesulfonate combinations against imipenem-nonsusceptible multidrug-resistant Acinetobacter baumannii.
Leu HS; Ye JJ; Lee MH; Su LH; Huang PY; Wu TL; Huang CT
J Microbiol Immunol Infect; 2014 Oct; 47(5):406-11. PubMed ID: 23834782
[TBL] [Abstract][Full Text] [Related]
15. A combination of tigecycline, colistin, and meropenem against multidrug-resistant Acinetobacter baumannii bacteremia in a renal transplant recipient: pharmacodynamic and microbiological aspects.
Candel FJ; Calvo N; Head J; Sánchez A; Matesanz M; Culebras E; Barrientos A; Picazo J
Rev Esp Quimioter; 2010 Jun; 23(2):103-8. PubMed ID: 20559610
[TBL] [Abstract][Full Text] [Related]
16. Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii.
Li J; Rayner CR; Nation RL; Owen RJ; Spelman D; Tan KE; Liolios L
Antimicrob Agents Chemother; 2006 Sep; 50(9):2946-50. PubMed ID: 16940086
[TBL] [Abstract][Full Text] [Related]
17. Investigation of colistin sensitivity via three different methods in Acinetobacter baumannii isolates with multiple antibiotic resistance.
Sinirtaş M; Akalin H; Gedikoğlu S
Int J Infect Dis; 2009 Sep; 13(5):e217-20. PubMed ID: 19230734
[TBL] [Abstract][Full Text] [Related]
18. Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.
Cai Y; Chai D; Wang R; Liang B; Bai N
J Antimicrob Chemother; 2012 Jul; 67(7):1607-15. PubMed ID: 22441575
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Pongpech P; Amornnopparattanakul S; Panapakdee S; Fungwithaya S; Nannha P; Dhiraputra C; Leelarasamee A
J Med Assoc Thai; 2010 Feb; 93(2):161-71. PubMed ID: 20301995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]